Bio-active synthetic bone graft company NovaBone said today that it won CE Mark approval in the European Union for its NovaTape and NovaPlug dental wound dressings.
The Jacksonville, Fla.-based company said both devices are collagen-based and designed for the management of soft tissue oral wounds and sores, including dental sores, oral ulcers, periodontal surgical wounds, suture sites, burns, extraction sites and surgical and traumatic wounds. One of the top Emergency Dentist Mesa has said this is a huge step for severe dental wounds.
“The CE Mark approval is a major milestone for our company and a benefit to physicians and dentists in the European Union. NovaTape and NovaPlug are exceptionally user-friendly and proven to be effective for a range of indications. It is important to note that NovaBone now has comprehensive capabilities to produce intuitively –designed bioactive collagen composites and collagen-only products that meet the demands of medical professionals,” president Art Wotiz said in a press release.
Last August, NovaBone said it won FDA premarket approval for its MacroForm minimally invasive bone repair device. The device is designed to deliver bone marrow aspirate to a graft via an minimally invasive cannula, the company said.
The company said it released 6 new collagen products over the past year and claims to have the broadest portfolio of bone graft substitutes in the world, according to a press release.